Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 14, 2015; 21(18): 5654-5662
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5654
Figure 1
Figure 1 Kaplan-Meier survival curves for the Barcelona Clinic Liver Cancer staging system for the whole cohort. There is a significant difference in survival between Barcelona Clinic Liver Cancer stages A and B patients. BCLC: Barcelona Clinic Liver Cancer stage.
Figure 2
Figure 2 Scatter plot graph for survival and alpha-fetoprotein ≥ 200 ng/mL in the whole cohort. Alpha-fetoprotein level was inversely correlated with patients’ survival. AFP: Alpha-fetoprotein.
Figure 3
Figure 3 Kaplan-Meier survival curves for modified Barcelona Clinic Liver Cancer for the whole cohort. There is a significant difference in survival between the three subgroups of either Barcelona Clinic Liver Cancer stage A or B patients. AFP: alpha-fetoprotein; BCLC: Barcelona Clinic Liver Cancer stage.